Published in Cancer Weekly, April 10th, 1995
He started by saying, "an important aspect of what I've researched is longevity. The fact is, that getting response to vaccine therapy and other kinds of biological therapy, the responding patient survives longer, and that is really the take home message I want you to understand. Unlike...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.